+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of the endogenous cannabinoid system in nicotine addiction: novel insights



Role of the endogenous cannabinoid system in nicotine addiction: novel insights



Frontiers in Psychiatry 6: 41



Several lines of evidence have shown that the endogenous cannabinoids are implicated in several neuropsychiatric diseases. Notably, preclinical and human clinical studies have shown a pivotal role of the cannabinoid system in nicotine addiction. The CB1 receptor inverse agonist/antagonist rimonabant (also known as SR141716) was effective to decrease nicotine-taking and nicotine-seeking in rodents, as well as the elevation of dopamine induced by nicotine in brain reward area. Rimonabant has been shown to improve the ability of smokers to quit smoking in randomized clinical trials. However, rimonabant was removed from the market due to increased risk of psychiatric side-effects observed in humans. Recently, other components of the endogenous cannabinoid system have been explored. Here, we present the recent advances on the understanding of the role of the different components of the cannabinoid system on nicotine's effects. Those recent findings suggest possible alternative ways of modulating the cannabinoid system that could have implication for nicotine dependence treatment.

(PDF emailed within 0-6 h: $19.90)

Accession: 058791310

Download citation: RISBibTeXText

PMID: 25859226

DOI: 10.3389/fpsyt.2015.00041


Related references

Endogenous cannabinoid and opioid systems and their role in nicotine addiction. Current Drug Targets 11(4): 440-449, 2010

The role of the cannabinoid system in nicotine addiction. Pharmacology, Biochemistry, and Behavior 81(2): 381-386, 2005

The role of the endogenous cannabinoid system in drug addiction. Drug News and Perspectives 21(3): 149-157, 2008

The endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptor. Addiction Biology 13(2): 143-146, 2008

The endogenous cannabinoid system modulates nicotine reward and dependence. Journal of Pharmacology and Experimental Therapeutics 326(2): 483-492, 2008

Conditional deletion of the cannabinoid receptor type 1 as a tool to dissect the role of the endogenous cannabinoid system in extinction of aversive memories. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 539 10, 2003

Targeted modulators of the endogenous cannabinoid system: future medications to treat addiction disorders and obesity. Current Psychiatry Reports 9(5): 365-373, 2007

Norlaudanosoline and nicotine increase endogenous ganglionic morphine levels: nicotine addiction. Cellular and Molecular Neurobiology 26(4-6): 1037-1045, 2006

Role of endogenous cannabinoid system in the gut. Sheng Li Xue Bao 65(4): 451-460, 2015

Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain. Pharmacological Research 110: 159-172, 2017

Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. International Journal of Tuberculosis and Lung Disease 7(9): 811-819, 2003

Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology 184(3-4): 504-513, 2006

Blocking cannabinoid receptors. Simultaneous control of overweight and nicotine addiction. Mmw Fortschritte der Medizin 146(10): 44-44, 2004

The role of the endogenous cannabinoid system in peripheral analgesia. Current Molecular Pharmacology 2(1): 134-139, 2010

The endogenous cannabinoid system and its role in nociceptive behavior. Journal of Neurobiology 61(1): 149-160, 2004